Japan's Keystone targets $440m for Fund V
Tokyo-based Keystone Partners is looking to raise around JPY50 billion ($440 million) for its fifth Japan-focused fund, which will make a combination of growth and turnaround investments.
Pre-marketing for Japan Revival Sponsor Fund V has already begun with a view to reaching a first close in mid-2022, Tomoaki Tsutsumi, Keystone’s representative director, told Mergermarket, AVCJ’s sister...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.